The mechanism of catechol estrogen-induced cardnogenesis could involve alkylation of critical cellular macromolecules by electrophilic quinoids. The o-quinones formed from peroxidase/P450-catalyzed oxidation of catechol estrogens have previously been implicated as the ultimate carcinogens. In the present study, we have shown that additional reactive intermediates can be produced from isomerization of the catechol estrogen o-quinones to highly electrophilic p-quinone methides (QMs). The o-quinones of the catechol estrogens were incubated at 37°C (pH 7.4) in the absence of GSH. Aliquots were removed at various times and combined with GSH. The GSH adducts were isolated and characterized by 'H-NMR, UV, and electrospray mass spectrometry. The o-quinone of 2-hydroxyestrone isomerized to two QMs; a QM stabilized by one alkyl substituent in the B ring, 2-OHE-QM1 (3-hydroxy-l-(10),3(4),5(6)-oestratrien-2,17-dione) and one having two alkyl substituents on the methylene group in the C ring, 2-OHE-QM2 (2-hydroxy-l(2),4(5),9(10)-oestratrien-3,17-dione). Only one QM was observed from the o-quinone of 4-hydroxyestrone, 4-OHE-QM2 (4-hydroxy-l(2),4(5),9(10)-oestratrien-3,17-dione) which is analogous to the C ring analog (2-OHE-QM2) from the o-quinone of 2-hydroxyestrone. The GSH adduct of 4-OHE-QM2 decomposed at pH 7.4 to give 9(ll)-dehydro-4-hydroxyestrone as the major product Finally, the disappearance of the estrogen o-quinone GSH adducts correlated with the formation of the GSH conjugates of the QMs. These data suggest that in cells with low levels of GSH, the formation of these potent electrophiles represents the major reaction pathway for estrogen o-quinones. The implications of the o-quinone/ QM pathway for the in vivo effects of catechol estrogens are not known; however, given the direct link between excessive exposure to endogenous estrogens and the *Abbreviations: ERT, estrogen replacement therapy; 2-OHE, 2-hydroxyestrone, 2,3-dihydroxy-l,3,5(10)-oestratrien-l7-one; 4-OHE, 4-hydroxyestrone, 3,4-dihydroxy-l,3,5(10)-oestratrien-17-one; estrone, 3-hydroxy-1,2,5-(10)-oestratnen-17-one; 9(ll)-dehydro-4-OHE, 9( 11 )-dehydro-4-hydroxyestrone, 3,4-dihydroxy-l,3,5(10),9(ll)-estratetraen-17-one); 9( 11 )-dehydro-2-OHE, 9(ll)-dehydro-2-hydroxyestrone, 2,3-dihydroxy-l,3,5(10),9(ll)-estratetraen-17-one); 2-OHE-QM1, 3-hydroxy-l(10)3(4),5(6)-oestratrien-2,17-dione; 2-OHE-QM2, 2-hydroxy-l(2).4(5), 9(10)-oestratrien-3,17-<lione; 4-OHE-QM2, 4-hydroxy-l(2),4(5),9(10>-oestratrien-3,17-dione; 4-OHE-QM1, 3-hydroxy-l(10),2(3)^(6)-oestratrien^,17-dione; DDQ, 23-dichloro-5,6-dicyano-l ,4-benzoquinone; P450, cytochrome P450; QM, quinone methide, 4-alkyl-2,5-cyclohexadien-l-one; o-quinone, 3,5-cyclohexadien-l,2-dione; LC-MS, liquid chromatography mass spectrometry; electrospray-MS, electrospray mass spectrometry.
Introduction
There is a clear association between excessive exposure to synthetic and endogenous estrogens and the development of cancer in several tissues including breast, endometrium, liver and kidney (1,2). Besides heredity, the known risk factors for women developing breast cancer are all associated with longer estrogen exposure; early menses, late menopause (3), and long term estrogen replacement therapy (ERT*) (4, 5) . Recent data indicate that as many as 30% of post-menopausal women in the US are currently receiving ERT (6) . Although there are many benefits of ERT including a substantial reduction in the risk of coronary heart disease and osteoporosis, such figures show the importance of fully understanding all the deleterious effects of estrogens including their potential to initiate and/or promote the carcinogenic process.
Although the carcinogenic effects of estrogens have been mainly attributed to hormonal properties (1), estrogens could also act as chemical carcinogens by binding to cellular macromolecules. The endogenous steroids estrone and 17P-estradiol are hydroxylated by various cytochrome P450 (P450) enzymes at several positions including the 2 and 4 carbons to form the 2-and 4-catechol metabolites (7, 8) . The catechol metabolites are oxidized to o-quinones that undergo redox cycling mediated through cytochrome P450/P450 reductase and thus could contribute to the carcinogenicity through the induction of oxidative damage to DNA (9, 10) . In addition to generating reactive oxygen species, o-quinones are Michael acceptors and covalent modification of DNA has been observed by the 32 Ppostlabeling method (11, 12) . Chemical or enzymatic activation of estrone or 17p*-estradiol and their catechol metabolites also leads to protein alkylation (13, 14) .
We have recently explored factors which influence the rate of P450-catalyzed formation of the o-quinones from 2-hydroxyestrone (2-OHE-Q) and 4-hydroxyestrone (4-OHE-Q) as well as from estrone in rat liver microsomes (15) . The initially formed o-quinones were trapped as their GSH conjugates which were separated and characterized by HPLC with electrospray-MS detection. Two A ring GSH conjugates were observed from the reaction of GSH at the C] and C 4 positions of 2-OHE-Q. In addition, a conjugate in which GSH had added twice to the A ring producing a di-GSH conjugate was detected. 4-OHE-Q gave only the C 2 A-ring GSH adduct as well as a di-GSH adduct. Preliminary data also suggested that both oquinones could isomerize to additional reactive intermediates; o-and p-quinone methides (QMs) (Figure 1 ). In the present investigation, we have confirmed QM formation from both 2-OHE-Q and 4-OHE-Q through the isolation and characterization of QM-GSH conjugates. These results suggest that the o-quinone/QM isomerization pathway may make a major contribution to the carcinogenic effects of catechol estrogens.
Materials and methods
All chemicals were purchased from Aldrich (Milwaukee, WI), Fisher Scientific (Itasca, IL) or Sigma (St Louis, MO) unless stated otherwise. 2-OHE and 4-OHE were either purchased from Sigma (St Louis, MO) or synthesized as described previously (16) . The o-quinone GSH conjugates and 9(ll)-dehydro-4-OHE were previously synthesized and characterized (15) . The products of o-quinone isomerization were prepared and characterized as follows. The o-quinones of the catechol estrogens were generated by 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ) oxidation in acetonitrile as described previously (15) . Briefly, the catechol estrogen (20 mg) was dissolved in 20 ml of acetonitrile containing 16 mg of DDQ and stirred at 25°C for 10 min. The acetonitrile solution was added in aliquots (2X10 ml) to 100 ml of potassium phosphate buffer (pH 7.4). The CH 3 CN was removed after each addition under vacuum. After 30 min incubation at 37°C, 2.5 ml of 0.2 M GSH was added followed by 5 ml perchloric acid. The products were isolated from the aqueous phase on C-18 extraction cartridges (3X6 ml capacity, J.T.Baker) and elutcd with methanol. The eluates were concentrated and subjected to semipreparative HPLC with an Ultrasphere ODS column (10X250 mm, Beckman) with a flow rate of 3.5 ml/min. The mobile phase consisted of the following sequence of solvents: 5% methanol in 0.25% perchloric acid/0.25% acetic acid (pH 3-5) for 5 min; increased to 40% CH 3 OH over 5 min; isocratic for 10 min; increased to 60% CH3OH over 10 min; isocratic for 7 min; increased to 90% CH3OH over the remaining 6 min of the run. Figure 2) ; UV (CH3OH) 214, 234, 290 nm; electrospray-MS, m/z 592 (100%) (MH + ); retention time 48 min. 
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, 310 nm; electrospray-MS, m/z 592 (100%) (MH + ); retention time 66 min. For kinetic studies, the o-quinones of the catechol estrogens in acetonitrile (750 |il) were combined with 14.25 ml potassium phosphate buffer (pH 7.4). At various time increments, 500 |il aliquots were removed and combined with 25 |il of 100 mM GSH. After the addition of perchloric acid (25 |il), the incubates were centrifuged at 13 000 r.p.m. for 6 min. Aliquots of the supernatant (100 |il) were analyzed directly by HPLC with a 4.6X150 mm Ultrasphere C-18 column (Beckman) on a Shimadzu LC-10A gradient HPLC equipped with an SIL-10A auto injector and SPD-I0AV UV detector set at 280 nm. The mobile phase consisted of 5% methanol in 0.25% perchloric acid/0.25% acetic acid (pH 3.5) at 1.0 ml/min for 5 min, increased to 40% CH3OH over 45 min, isocratic for 5 min, and increased to 90% CH3OH over the last 20 min. The rate of QM formation was determined from the increase in peak area ratio of the QM-GSH adducts.
HPLC experiments were performed on the above mentioned Shimadzu HPLC system. Peaks were integrated with Shimadzu EZ-Chrom software and a 486-33 computer. UV spectra were measured with a Hewlett Packard Model 8452 diode array UV/Vis spectrophotometer and 'H NMR spectra were obtained with a Varian XL-300 spectrometer at 300 MHz. Electrospray mass spectra were obtained using a Hewlett-Packard 5989B MS Engine quadrupole mass spectrometer equipped with a ChemStation data system and high flow pneumatic nebulizer-assisted electrospray LC-MS interface. The mass spectrometer was interfaced to the above mentioned Hewlett-Packard gradient HPLC system. The quadrupole analyzer was maintained at I2O°C. and unit resolution was used for all measurements. Nitrogen at a pressure of 80 p.s.i. was used for nebulization of the HPLC effluent, and nitrogen bath gas at 350°C and a flow rate of 50 ml/min was used for evaporation of solvent from the electrospray. The range m/z 200-900 was scanned over ~2 s during LC-MS.
Results and discussion
Previous work has shown that enzymatic oxidation of catechol estrogens generates o-quinones which are trapped in situ by GSH (15) . The trapping reaction is very efficient due to the high concentration of GSH in the medium (1.0 mM), and the relatively fast rate of addition of thiols to o-quinones relative to amino or hydroxyl groups (17,18). In addition, QM derived GSH adducts were not observed under these experimental conditions as the rate of trapping of the o-quinone by GSH is much faster than the rate of isomerization of the o-quinone to the QM (19, 20) . In the absence of GSH, a time-dependent decrease in o-quinone GSH adducts was observed ( Figure 3 ). Preliminary data implied that the o-quinones of both catechol estrogens isomerize to QMs shown in Figure 1 . 2-OHE-oquinone has the potential to form two QMs, a QM stabilized by two alkyl substituents on the methylene group in the Cring and a QM with only one alkyl substituent in the B-ring. In contrast, 4-OHE-o-quinone can isomerize to the potentially more stable C-ring p-QM as well as the B-ring o-QM. From the pseudo-first order rate of disappearance of the o-quinone di-GSH adducts the half-lives of the o-quinones were determined (Table I ). The o-quinone from 2-OHE was found to be 17-fold more reactive in aqueous solution compared to the 4-OHE-o-quinone. Exogenous 4-OHE, although not 2-OHE, is carcinogenic in hamsters (21), possibly because of the slower rate of isomerization of 4-OHE-Q to highly electrophilic QMs. In both GSH trapping studies, new GSH conjugates appear over the course of the experiment which may have been QM GSH adducts; however the adducts were unstable and isolation and spectral characterization were not successful.
In the present study, we unequivocally establish that both catechol estrogen o-quinones isomerize to QMs by isolating and characterizing the QM-SG conjugates. In contrast to the o-quinone GSH adducts, the QM-SG adducts were very unstable at neutral pH with essentially complete decomposition occurring within 2-3 h. The stability of these adducts was increased sufficiently to allow spectral characterization by the addition of perchloric acid in the isolation procedure. The 'H-NMR spectra of the diastereoisomers produced from reaction of GSH with 2-OHE-QMl (Figure 2) showed intact aromatic resonances corresponding to two protons. o-Quinones give Aring substituted GSH conjugates which would show only one The rate of disappearance of the Di-SG adduct for each o-quinone from reference 15.
•The rate of appearance of 2-OHE-QM1-SG. The rate of appearance of 2-OHE-QM2-SG. The rate of appearance of 4-OHE-QM2-SG.
aromatic resonance in the spectrum. The benzylic CH resonance at 4.18 p.p.m. was assigned based on a NOE experiment which showed enhancement of the aromatic H4 proton. The cysteine a and P protons of GSH were identified by decoupling the cysteine a resonance at 4.8 p.p.m. The other GSH resonances are also clearly visible in the 'H-NMR and electrospray-MS precisely shows the addition of the mass of GSH to 2-OHE (MW 591). Based on the spectral data, we have assigned the conjugates as the diastereoisomers resulting from attack of chiral GSH at the prochiral C 6 benzyl carbon of the 2-OHE-QM 1 (Figure 1 , 2-OHE-QM 1-SG).
The other GSH peak which appears at a 50-fold slower rate during the time-dependent GSH trapping experiments is a structural isomer of 2-OHE-QM 1-SG as confirmed by LC-MS. The ' H-NMR spectrum also contained two aromatic resonances indicating GSH had not added to the A-ring. The Cg benzylic resonance at 4.18 p.p.m. was absent from the spectrum suggesting reaction with the C-ring QM isomer, 2-OHE-QM2 (Figure 1) . The G, carbon of 2-OHE-QM2 is also a prochiral center and diastereoisomers were expected; however, only one peak was observed by HPLC using various mobile phase compositions. These data suggest that geometry constraints only allow reaction with GSH from one side of the molecule. Finally, we have also identified a compound with an additional site of unsaturation compared to 2-OHE. We believe this product is 9(ll)-dehydro-2-OHE which could be formed by elimination of GSH from 2-OHE-QM2-SG as shown in Figure 1 . Alternatively, removal of the H n and rearomatization of 2-OHE-QM2 could potentially occur (22) . A similar reaction has previously been reported for 4-OHE-QM2 (15) .
LC-MS studies have also confirmed that p-QM, 4-OHE-QM2 reacts with GSH to give 4-OHE-QM2-SG. As observed with 2-OHE-QM2, only one peak was observed probably due to the above mentioned geometry constraints. This conjugate is very unstable even under acidic conditions and 'H-NMR analysis of the isolated product showed complete decomposition to 9(ll)-dehydro-4-OHE. On-line LC-MS analysis did reveal the expected molecular weight of a GSH conjugate and the UV spectrum resembled 4-OHE consistent with 4-OHE-QM2-SG. As yet we have not obtained evidence that the o-QM, 4-OHE-QM1 is formed; however, there are additional peaks that increase with time that have not been identified. The o-quinone of the model AB ring analog of 4-OHE, 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene does isomerize to an o-QM suggesting this reaction is possible for 4-OHE-Q; however, formation of the p-QM from this model compound represents the major product of o-quinone degradation (15) .
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Finally, kinetic experiments have established that the formation of QMs correlates with the disappearance of the estrogen o-quinones (Table I, Figure 3 ). The rate of formation of 2-0HE-QM2 is 50-fold slower than 2-OHE-QM 1 suggesting that removal of Hg is more facile than H 9 elimination perhaps for steric reasons. These data show that estrogen o-quinones do not decompose to give Diels-Alder products or other dimeric compounds under physiological conditions. It is quite possible however, that in aprotic organic solvents these reactions predominate since the isomerization mechanism requires catalysis by water or basic residues to remove H^ or H 9 (23) .
The relative importance of QM formation to the biological effects of catechol estrogens is not known; however, QMs have vastly different chemistry compared to o-quinones and their formation could alter the effects of catechol estrogens in vivo. In particular, o-quinones are redox active compounds as well as alkylating agents whereas QMs are considerably more electrophilic than o-quinones (19) with very little capacity for redox chemistry (24) . This suggests that the o-quinones are responsible for catechol estrogen mediated induction of oxidative damage to DNA, whereas QMs could only covalently modify DNA. o-Quinones can also alkylate DNA, but their site(s) of alkylation on DNA might be quite different, leading to alterations in the relative efficiency of DNA repair. For example, a recent report has shown that 4-OHE-Q modifies adenine at the C 8 position on the purine ring under reductive conditions (25) . In contrast, QMs formed from bioreductive alkylating agents tend to react with the exocyclic amino groups of deoxyguanosine and deoxyadenosine (26, 27) .
In summary, data have been presented on the isomerization of catechol estrogen o-quinones to highly electrophilic QMs. These data suggest that in cells with low levels of GSH, this is the major reaction pathway for these o-quinones. The implications of the o-quinone/QM pathway for the in vivo effects of catechol estrogens are not known; however, given the direct link between excessive exposure to endogenous estrogens and the enhanced risk of breast cancer, the potential for formation of additional reactive intermediates needs to be explored.
